Search Within

Gynecologic Medicine Service

Formats
  1. Journal Article (1104)
  2. Meeting Abstract (902)
  3. Review (55)
  4. Book Section (46)
  5. Editorial (36)
  6. Guidelines (22)
  7. Correspondence (9)
  8. Miscellaneous (3)
  9. Research Letter (2)
  10. Book Whole (1)
Groups
  1. Solid Tumor Oncology Division (2180)
  2. Department of Medicine (2174)
  3. Gynecology Disease Management Team (1877)
  4. GDMT, Medicine (1859)
  5. Surgery (603)
  6. GDMT, Surgery (479)

More Groups

People
  1. Carol Aghajanian (615)
  2. Nadeem Abu-Rustum (292)
  3. Martee Hensley (290)
  4. Roisin O'Cearbhaill (273)
  5. Vicky Makker (269)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (75)
  2. 2024 (167)
  3. 2023 (171)
  4. 2022 (209)
  5. 2021 (163)
  6. 2020 (203)

More Years

Publications
  1. Journal of Clinical Oncology (458)
  2. Gynecologic Oncology (420)
  3. International Journal of Gynecological Cancer (161)
  4. Annals of Oncology (117)
  5. Clinical Cancer Research (71)
  6. Cancer Research (55)

More Publications

Publishers
  1. American Society of Clinical Oncology (498)
  2. Elsevier B.V. (446)
  3. Lippincott Williams & Wilkins (188)
  4. American Association for Cancer Research (173)
  5. Oxford University Press (144)
  6. Elsevier Inc. (128)

More Publishers

Results (2180)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pilot study evaluating presence of crown-like structures in high grade endometrial carcinoma
    Meeting Abstract

    Shu, C. A.; Iyengar, N. M.; Giri, D. D.; Chiang, S.; Williams, S.; Konner, J. A.; Aghajanian, C.; Hudis, C. A.; Dannenberg, A.; Makker, V.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Prevalence of hypomagnesemia in patients with HER2-positive breast cancer receiving pertuzumab treatment
    Meeting Abstract

    Proverbs-Singh, T. A.; Cadoo, K. A.; Torre, G.; Patil, S.; Gucalp, A.; Dang, C. T.; Hudis, C. A.; Glezerman, I. G.; Traina, T. A.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Association between renal function and chemotherapy-related toxicity in older adults with cancer
    Meeting Abstract

    Peterson, L. L.; Hurria, A.; Feng, T.; Mohile, S. G.; Owusu, C.; Klepin, H. D.; Gross, C. P.; Lichtman, S. M.; Gajra, A.; Glezerman, I. G.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Is next generation sequencing (NGS) ready for routine clinical practice in gliomas? Results of a prospective study utilizing the MSK-IMPACT assay
    Meeting Abstract

    Omuro, A. M. P.; Zehir, A.; Cheng, D. T.; Berger, M. F.; Hyman, D. M.; Solit, D. B.; Baselga, J.; Ladanyi, M.; Arcila, M. E.; Hameed, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Carboplatin hypersensitivity reactions (HSR) in carboplatin retreatment for recurrent ovarian cancer
    Meeting Abstract

    O'Cearbhaill, R. E.; Hyman, D. M.; Tew, W. P.; Iasonos, A.; Cangemi, N. A.; Aghajanian, C.; Bell-Mcguinn, K. M.; Makker, V.; Hensley, M. L.; Konner, J. A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study
    Meeting Abstract

    Myers, A. P.; Filiaci, V. L.; Zhang, Y. P.; Pearl, M.; Behbakht, K.; Makker, V.; Hanjani, P.; Zweizig, S.; Burke, J. J.; Downey, G.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Neoadjuvant chemotherapy (NACT) selection for advanced stage ovarian cancer (AOC) at a comprehensive cancer center
    Meeting Abstract

    Mueller, J. J.; Alvi, F. A.; El Haraki, A. S.; Eriksson, A. G.; Zhou, Q.; Iasonos, A.; O'Cearbhaill, R. E.; Chi, D.; Abu Rustum, N.; Zivanovic, O.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • The MILO (MEK inhibitor in low-grade serous ovarian cancer)/ENGOT-ov11 study: A multinational, randomized, open-label phase 3 study of binimetinib (MEK162) versus physician's choice chemotherapy in patients with recurrent or persistent low-grade serous carcinomas of the ovary, fallopian tube, or primary peritoneum
    Meeting Abstract

    Monk, B. J.; Grisham, R. N.; Marth, C.; Banerjee, S. N.; Hilpert, F.; Coleman, R. L.; Pujade-Lauraine, E.; Pignata, S.; Mirza, M. R.; Oza, A. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Outcomes of stage IA polyp-limited vs endometrium-limited epithelial high grade endometrial carcinoma (EMC)
    Meeting Abstract

    Liang, L.; Perez, A. R.; Cangemi, N. A.; Zhou, Q.; Iasonos, A.; Alektiar, K. M.; Abu Rustum, N.; Makker, V.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase II study of alisertib (MLN8237) in recurrent or persistent uterine leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-0231D)
    Meeting Abstract

    Hyman, D. M.; Sill, M.; Cho, J. K.; Lankes, H. A.; Piekarz, R.; Hensley, M. L.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save